Hutch News
Results per Page:
COVID-19 complacency: ‘A hard shift for the immunocompromised’
Even with vaccines and antivirals, cancer patients and many others are still vulnerable to infection; some safety tips for this evolving pandemic
Tip Sheet: Fred Hutch experts tackle long COVID, improving outcomes for leukemia patients – and tips on staying healthy
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: New findings on immune response to COVID-19, new research from San Antonio Breast Cancer Symposium — and Fred Hutch expert predictions for 2022
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Fred Hutch experts and omicron, closing gaps in indigenous health disparities, new leaders in DEI and data science — and ASH 2021
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: How to diversify vaccine clinical trials, 30 years of science education, Trevor Noah talks to Hutch scientists — and more
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: New MacArthur ‘genius,’ returning to school during COVID-19 and the science of race and racism
Summaries of recent Fred Hutch research findings and other news
Scientists boost immune function in mice by mimicking natural renewal processes
New study identifies molecular players in ‘dead man’s switch’ that triggers key immune organ’s regeneration after damage
Q&A: Returning to school, post-transplant
As schools reopen for in-person learning, what should bone marrow transplant recipients do?
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Summaries of recent Fred Hutch research findings and other news
Tip Sheet: Cancer-busting broccoli sprout pills in space, trauma and healing among Indigenous people, how to boost HPV vaccinations
Summaries of recent Fred Hutch research findings and other news
How studies of coronavirus immunity can inform better vaccines, treatments
Scientists look for broad-acting antibodies that could protect against new variants of SARS-CoV-2 — and maybe a future SARS-3
Cancer patients and the COVID-19 vaccines
Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more
A short primer on coronavirus biology
Hutch virologist explains viral pandemics and COVID-19
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
Insights from infants could inform HIV vaccine design
Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
mRNA: the future of vaccines?
The Gottardo Laboratory, Vaccine and Infectious Disease Division
Teacher, mom — and living immunotherapy proof of principle
Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.
Using a virus to teach the immune system to kill cancer
‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma
Nearly half of U.S. men actively infected with HPV, study finds
HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated
New study looks at how persistent organic pollutants affect vaccines
New Fred Hutch study looks at whether persistent organic pollutants can undercut vaccines